Free Trial Information
BioCentury | May 16, 2011
Financial News

Alkermes completes debt financing

...Neurology, Endocrine, Autoimmune Date completed: 5/9/11 Type: Debt financing Raised: $450 million Investors: Morgan Stanley; HSBC Investment Bank...
Read More
BioCentury | Jan 14, 2008
Company News

Panacos management update

Panacos Pharmaceuticals Inc. (NASDAQ:PANC), Watertown, Mass. Business: Infectious Hired: Jane Henderson as chief financial and business officer, formerly managing director at HSBC's investment banking division covering biotechnology companies WIR Staff Infectious...
Read More
BioCentury | May 18, 2000
Financial News

Xenogen raises $30.5 million

...Calif.), a developer of in vivo cell imaging technology, completed a mezzanine round. Investors included HSBC Investment Bank...
Read More
Items per page:
1 - 3 of 3
BioCentury | May 16, 2011
Financial News

Alkermes completes debt financing

...Neurology, Endocrine, Autoimmune Date completed: 5/9/11 Type: Debt financing Raised: $450 million Investors: Morgan Stanley; HSBC Investment Bank...
Read More
BioCentury | Jan 14, 2008
Company News

Panacos management update

Panacos Pharmaceuticals Inc. (NASDAQ:PANC), Watertown, Mass. Business: Infectious Hired: Jane Henderson as chief financial and business officer, formerly managing director at HSBC's investment banking division covering biotechnology companies WIR Staff Infectious...
Read More
BioCentury | May 18, 2000
Financial News

Xenogen raises $30.5 million

...Calif.), a developer of in vivo cell imaging technology, completed a mezzanine round. Investors included HSBC Investment Bank...
Read More
Items per page:
1 - 3 of 3